Literature DB >> 26989896

MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid.

Klaus-Peter Dieckmann1, Meike Spiekermann, Thomas Balks, Raphael Ikogho, Petra Anheuser, Werner Wosniok, Thomas Loening, Jörn Bullerdiek, Gazanfer Belge.   

Abstract

BACKGROUND: microRNAs (miRs)-371-3 are suggested to be novel biomarkers of germ cell tumors (GCTs), but their specificity is unresolved. We aimed at clarifying the origin of miR 371a-3p by measuring this miR in peripheral vein blood, and in fluids present in the vicinity of GCTs.
METHODS: miR-371a-3p levels were measured by quantitative PCR in 9 tumor surrounding hydroceles and in cubital vein blood (CVB) and testicular vein blood (TVB) of 64 GCT patients, 51 with clinical stage (CS) 1, 13 with CS2-3. Thirty three CS1 cases had also postoperative CVB measurement. TVB miR levels were compared with those of CVB. Associations with clinical factors were analyzed statistically.
RESULTS: TVB miR levels were 294-fold, 80-fold and 4.6-fold higher than those in CVB of CS1 patients, CS2-3 patients and controls, respectively. Neoplastic hydrocele fluid comprised of very high miR levels. In CS1, miR levels dropped to normal postoperatively. Statistically, CVB miR levels are significantly associated with tumor size (p = 0.0211) and testis length (p = 0.0493). TVB miR levels are associated with testis length (p = 0.0129).
CONCLUSIONS: This study provides evidence for the origin of circulating miR 371a-3p molecules from GCT cells. miR-371a-3p represents a specific serum biomarker for germ cell cancer.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26989896     DOI: 10.1159/000444303

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  19 in total

1.  Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series.

Authors:  Petra Anheuser; Arlo Radtke; Christian Wülfing; Jennifer Kranz; Gazanfer Belge; Klaus-Peter Dieckmann
Journal:  Urol Int       Date:  2017-06-07       Impact factor: 2.089

2.  MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors.

Authors:  Stefan Schönberger; Mahsa Mir Mohseni; Jörg Ellinger; Giao Vu Quynh Tran; Martina Becker; Alexander Claviez; Carl-Friedrich Classen; Barbara Hermes; Pablo Hernáiz Driever; Norbert Jorch; Melchior Lauten; Marcus Mehlitz; Niklas Schäfer; Johanna Scheer-Preiss; Dominik T Schneider; Anja Troeger; Gabriele Calaminus; Dagmar Dilloo
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-16       Impact factor: 4.553

Review 3.  Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours.

Authors:  Kristian Almstrup; João Lobo; Nina Mørup; Gazanfer Belge; Ewa Rajpert-De Meyts; Leendert H J Looijenga; Klaus-Peter Dieckmann
Journal:  Nat Rev Urol       Date:  2020-03-10       Impact factor: 14.432

4.  The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, Has a Very Rapid Decay in Patients with Clinical Stage 1.

Authors:  Arlo Radtke; Finja Hennig; Raphael Ikogho; Johannes Hammel; Petra Anheuser; Christian Wülfing; Gazanfer Belge; Klaus-Peter Dieckmann
Journal:  Urol Int       Date:  2018-04-26       Impact factor: 2.089

Review 5.  Testicular cancer.

Authors:  Liang Cheng; Peter Albers; Daniel M Berney; Darren R Feldman; Gedske Daugaard; Timothy Gilligan; Leendert H J Looijenga
Journal:  Nat Rev Dis Primers       Date:  2018-10-05       Impact factor: 52.329

6.  microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.

Authors:  Ton van Agthoven; Wil M H Eijkenboom; Leendert H J Looijenga
Journal:  Cell Oncol (Dordr)       Date:  2017-06-13       Impact factor: 6.730

7.  Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test).

Authors:  Ton van Agthoven; Leendert H J Looijenga
Journal:  Oncotarget       Date:  2016-07-27

8.  Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?

Authors:  A Radtke; J-F Cremers; S Kliesch; S Riek; K Junker; S A Mohamed; P Anheuser; G Belge; K-P Dieckmann
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-17       Impact factor: 4.553

9.  Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice.

Authors:  Michal Chovanec; Costantine Albany; Michal Mego; Rodolfo Montironi; Alessia Cimadamore; Liang Cheng
Journal:  Front Oncol       Date:  2018-11-28       Impact factor: 6.244

10.  Small RNAs in Seminal Plasma as Novel Biomarkers for Germ Cell Tumors.

Authors:  Nina Mørup; Rytis Stakaitis; Ieva Golubickaite; Meritxell Riera; Marlene Danner Dalgaard; Mikkel H Schierup; Niels Jørgensen; Gedske Daugaard; Anders Juul; Kristian Almstrup
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.